Finch Therapeutics Group Cash from Financing (TTM) Insights

Finch Therapeutics Group Inc (FNCH)

2.30 -0.19 (-7.63%) USD | NASDAQ | May 03, 16:00

2.36 +0.06 (+2.61%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-16.16M
September 30, 2023	-16.10M
June 30, 2023	-16.06M
March 31, 2023	-1.291M
December 31, 2022	14.87M
September 30, 2022	14.89M
June 30, 2022	14.90M

Date	Value
March 31, 2022	1.748M
December 31, 2021	119.11M
September 30, 2021	118.81M
June 30, 2021	208.67M
March 31, 2021	208.85M
December 31, 2020	91.48M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-16.16M

Minimum

Dec 2023

208.85M

Maximum

Mar 2021

57.21M

Average

14.89M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks